Letter From the Director

Dear ADRC Community,
Wherever you are reading this, we want to send a warm welcome to each of you. As we approach the holiday season, we thank you for your support that has facilitated our pursuit of research and educational breakthroughs and enhanced patient care at the Boston University School of Medicine Alzheimer’s Disease Research Center (ADRC). This fall, our center remains resilient and productive, with the faculty and staff of the ADRC busy and hard at work supporting the wide variety of Alzheimer’s disease (AD) related research and community-building efforts at the ADRC. The BU ADRC continues to focus on cutting-edge research, proactive community engagement, and training of the next generation of AD researchers. Major new BU ADRC research initiatives include studies on repetitive head injury and risk for Alzheimer’s disease and Alzheimer’s disease-related disorders (ADRDs) including Chronic Traumatic Encephalopathy (CTE); advanced neuropathology; genetics; biostatistical modeling; biomarker discovery; and molecular profiling. The BU ADRC has been highly scientifically productive, contributing > 430 original scientific reports to the literature since 2015. Beyond these scientific accomplishments, our center continues to grow and expand in its vision, leading innovative efforts in genetics, bioinformatics, and novel biomarker development, among other areas. We greatly appreciate the support of the National Institutes of Health, which funds major research efforts of our center, as well as individual donors dedicated to ending Alzheimer’s disease. Thank you for your continued support of our center and its mission, as none of our efforts would be possible without the dedication of our patients and their families. BU ADRC continues to have a bright future, with many new investigators joining our team who are part of a myriad of projects furthering the understanding and treatment of Alzheimer’s disease and Alzheimer’s disease-related disorders.
Thank you for your interest and support of the Alzheimer’s Disease Research Center at BUSM.
Sincerely,
Neil W. Kowall, MD
ADRC Director
Professor of Neurology and Pathology